Free Trial

Wealth Enhancement Advisory Services LLC Has $6.83 Million Stake in The Clorox Company $CLX

Clorox logo with Consumer Staples background

Key Points

  • Wealth Enhancement Advisory Services LLC has reduced its stake in The Clorox Company by 5.6%, leaving them with 54,717 shares valued at approximately $6.83 million.
  • The company's quarterly earnings beat expectations, reporting $2.87 earnings per share and a revenue of $1.99 billion, reflecting a 4.5% increase compared to the same quarter last year.
  • Clorox recently announced a quarterly dividend of $1.24, with a yield of 4.1%, demonstrating a strong commitment to returning value to shareholders.
  • MarketBeat previews the top five stocks to own by October 1st.

Wealth Enhancement Advisory Services LLC trimmed its stake in The Clorox Company (NYSE:CLX - Free Report) by 5.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 54,717 shares of the company's stock after selling 3,217 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Clorox were worth $6,831,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wood Tarver Financial Group LLC acquired a new stake in Clorox in the fourth quarter valued at $31,000. Ransom Advisory Ltd acquired a new stake in Clorox in the first quarter valued at $35,000. GW&K Investment Management LLC increased its holdings in Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after purchasing an additional 208 shares during the period. Roble Belko & Company Inc increased its holdings in Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after purchasing an additional 211 shares during the period. Finally, IMA Advisory Services Inc. acquired a new stake in Clorox during the 1st quarter worth about $58,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company's stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.57% of the company's stock.

Clorox Price Performance

Shares of NYSE CLX opened at $120.43 on Wednesday. The Clorox Company has a fifty-two week low of $116.53 and a fifty-two week high of $171.37. The stock has a market cap of $14.73 billion, a price-to-earnings ratio of 18.47, a PEG ratio of 0.96 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The firm's 50-day simple moving average is $123.82 and its 200 day simple moving average is $130.86.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. During the same quarter last year, the firm earned $1.82 EPS. The firm's revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.1%. Clorox's dividend payout ratio (DPR) is presently 76.07%.

Analyst Ratings Changes

CLX has been the subject of a number of recent analyst reports. Wells Fargo & Company decreased their price target on Clorox from $138.00 to $130.00 and set an "equal weight" rating for the company in a report on Friday, September 5th. Morgan Stanley decreased their price target on Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. JPMorgan Chase & Co. increased their price target on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a report on Monday, September 8th. Barclays decreased their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. Finally, UBS Group decreased their price target on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of "Reduce" and a consensus target price of $142.18.

Check Out Our Latest Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.